Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Zhongxun Medical Technology is a China-based healthcare services company operating as a subsidiary within the Zhongchao group. The company appears to focus on patient management and follow-up services, internet healthcare support, and pharmaceutical-related services rather than on developing proprietary therapeutics. Public disclosures from Zhongchao indicate that Shanghai Zhongxun has been used to deliver branded patient management services under the "Zhongxun" name and to support patients with oncology and other major diseases in China. Available evidence does not indicate a traditional biotech drug pipeline, platform technology, or clinical-stage therapeutic assets. It is better characterized as a health-tech and patient services business supporting care delivery and disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Zhongxun Medical Technology.